Many patients describe completing their health assessment and receiving approval within 24 hours, sometimes faster
Then the AHLA warning came out
Its also approved for fatty liver disease (more specifically, metabolic dysfunction-associated steatohepatitis, or MASH) and to lower cardiovascular risk in adults with obesity or overweight and heart disease
For women with polycystic ovary syndrome or insulin resistance, the improvements in metabolic markers may have additional hormonal benefits
Much like any other disease state, if one type of therapy isnt feasible due to cost, access, tolerance, or just ineffectiveness for a specific patient, then pursuing an alternate treatment strategy is a very reasonable course of action, says Maselli
Furthermore, clinical trials have demonstrated that clients using Semaglutide GLP-1 for weight management experience substantial medical weight loss